Anderson 1999.
Methods | Case series Duration: 24 months | |
Participants | N = 30 enrolled
Primary condition: Most had back and/or leg pain, In 47% associated with failed back surgery syndrome
Baseline pain score: Mean 78.5 (SD 15.9, Range 39 to 100)/100 VAS
Time since onset: 8 years (SD 9 years, Range 5 to 24 years)
Mean age: 58 years (SD 13 years)
Female: 53% Previous opioid analgesia: All patients had taken systemic narcotics before study enrolment, and 28/30 (93%) were taking them regularly at time of enrolment |
|
Interventions | Intrathecal morphine Initial dose: Mean 1 mg/day Titration up to 25 mg/day at endpoint Supplemental analgesia: Allowed. At 24 months, 6/20 (30%) patients used supplemental oral narcotics |
|
Outcomes | Discontinuation due to adverse events
Adverse events
Discontinuation due to insufficient pain relief
Pain (continuous) and pain relief (proportion with at least 50% relief) Function |
|
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Comparability of patients at baseline and follow‐up (continuous data) All outcomes | High risk | Due to attrition |
Selection method random or consecutive | Low risk | Consecutive |
Prospective | Low risk | Prospective |
Free from confounding treatment(s) | High risk | Supplemental analgesia allowed |
Patient compliance monitored and reported at at least 85%? | Low risk | Pump administration |
Attrition and right censoring less than 15% (continuous data) All outcomes | High risk | Higher attrition |
Funding from a source without financial conflict of interest? | High risk | Funding from Medtronic |